tert-Butyl (2,5-difluoropyridin-4-yl)carbamate, 97%, 5g

(3R,4S)-1-Boc-3-amino-4-hydroxy-pyrrolidine, 95.0%, 100mg

5,10,15,20-Tetrakis(pentafluorophenyl)-21H,23H-porphine, 97%, 10g

TAZEMETOSTAT, 98%, 1g

3-(Perfluoropropyl)-1,2-propenoxide, 97.0%, 1g

2-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzaldehyde, 95.0%, 100g

Ethyl 5-amino-4-cyano-1-phenyl-1H-pyrazole-3-carboxylate, 95.0%, 5g

9-Julolidine boronic acid, 95.0%, 1g

3-(1,3,5-trimethyl-1H-pyrazol-4-yl)propanoic acid hydrochloride, 95.0%, 5g

4-(2-oxo-1,2-dihydropyridin-1-yl)butanoic acid, 95.0%, 500mg

Methyl 1-bromoisoquinoline-3-carboxylate, 5g

1-Benzyl-3-methylimidazolium dicyanamide, 98%, 100g

2-Cyclopentyl-ethylamine hydrochloride, 95.0%, 5g